The estimated Net Worth of Timothy Gertsch is at least $83 mil dollars as of 11 September 2023. Timothy Gertsch owns over 26,250 units of agilon health, inc stock worth over $83,046 and over the last few years Timothy sold AGL stock worth over $0.
Sign up
Timothy Gertsch AGL stock SEC Form 4 insiders trading
Timothy has made over 1 trades of the agilon health, inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Timothy exercised 26,250 units of AGL stock worth $196,613 on 11 September 2023.
The largest trade Timothy's ever made was exercising 26,250 units of agilon health, inc stock on 11 September 2023 worth over $196,613. On average, Timothy trades about 6,563 units every 0 days since 2023. As of 11 September 2023 Timothy still owns at least 25,871 units of agilon health, inc stock.
You can see the complete history of Timothy Gertsch stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Timothy Gertsch's mailing address?
Timothy's mailing address filed with the SEC is C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN, TX, 78723.
Insiders trading at agilon health, inc
Over the last 4 years, insiders at agilon health, inc have traded over $2,766,210,380 worth of agilon health, inc stock and bought 408,814 units worth $1,411,859 . The most active insiders traders include Investment Associates Ix, L..., Veeral Desai, eBenjamin Shaker. On average, agilon health, inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,807,999. The most recent stock trade was executed by Benjamin Kornitzer on 14 March 2024, trading 5,434 units of AGL stock currently worth $17,443.
What does agilon health, inc's logo look like?
Complete history of Timothy Gertsch stock trades at agilon health, inc
agilon health, inc executives and stock owners
agilon health, inc executives and other stock owners filed with the SEC include:
-
Steven Jackson Sell,
Pres, CEO & Director -
Dr. Benjamin Kornitzer M.D.,
Chief Medical & Quality Officer -
Mat Varghese,
Chief People Officer -
Ben Shaker,
Chief Markets Officer -
Claire Mulhearn,
Chief Communications & Public Affairs Officer -
Lisa Ali,
Chief Compliance Officer -
Lyn Amor Macaraeg,
VP of Legal Services -
Matthew Dale Gillmor CFA,
VP of Investor Relations -
Girish Venkatachaliah,
Chief Technology Officer -
Timothy S. Bensley,
Chief Financial Officer -
Silvana Battaglia,
Director -
Timothy Bensley,
Chief Financial Officer -
Joan Danieley,
Chief Administrative Officer -
Theodore Halkias,
Chief Business Officer -
Michelle A Gourdine,
Director -
Veeral Desai,
Chief Strategy & Dev. Officer -
Lisa Dombro,
Exper. & Innovation Officer -
Clay Richards,
Director -
Sharad Mansukani,
Director -
Benjamin Kornitzer,
Chief Med. & Quality Officer -
Benjamin Shaker,
Chief Markets Officer -
Ronald A Williams,
Director -
Glenn Sobotka,
Chief Accounting Officer -
Girish Venkatachaliah,
Chief Technology Officer -
John William Wulf,
Director -
Michael L Smith,
Director -
Karen Mc Loughlin,
Director -
Richard J Schnall,
Director -
Investment Associates Ix, L...,
-
Steven Sell,
CEO & President -
Jeffrey A. Schwaneke,
Chief Financial Officer -
Diana Mckenzie,
Director -
Priscilla Kasenchak,
Chief Accounting Officer -
Timothy Gertsch,
Chief Accounting Officer